Project Details
Short title | IcICLLe: Assessment of the Mechanism of Action of Ibrutinib (PCI-32765) in B-cell Receptor Pathway Inhibition in CLL |
---|---|
Status | Finished |
Effective start/end date | 14/03/14 → 31/12/23 |
Funding
- PHARMACYCLICS INC
Short title | IcICLLe: Assessment of the Mechanism of Action of Ibrutinib (PCI-32765) in B-cell Receptor Pathway Inhibition in CLL |
---|---|
Status | Finished |
Effective start/end date | 14/03/14 → 31/12/23 |